leadf
logo-loader
viewArcher Materials Ltd

Archer Materials strengthens human health vertical with biotechnology manager appointed

The company’s graphene-based biosensor technology development has an ongoing focus on exploiting the advanced chemistry of its new graphene materials to arrive at a minimal viable product.

Archer Materials Ltd - Archer Materials strengthens human health vertical with appointment of Dr Rebecca Soffee as biotechnology manager
Archer is a materials technology company developing materials in quantum computing, biotechnology and lithium-ion batteries

Archer Materials Ltd (ASX:AXE) (OTCMKTS:ARRXF) has strengthened its human health vertical through the appointment of Dr Rebecca Soffe as biotechnology manager.

This newly created role is part of Archer’s strategy to commercially develop materials technology and the immediate priority is to technically develop the intellectual property claims in Archer’s international patent application relevant to the company’s graphene-based biosensor technology.

The appointment will build next-stage biosensor prototypes in the $150 million semiconductor chip foundry in Sydney that Archer commercially accesses, lead Archer’s collaboration with University of Adelaide ARC Graphene Hub and work with a leading German biotech company.

This comes as Archer progresses the development of biotechnology towards commercialisation.

“Talented nanotechnologist”

Chief executive officer Dr Mohammad Choucair said: “Dr Soffe is a talented nanotechnologist with an exceptional background in building biosensor devices.

“Her track record for high impact innovation related to ‘Lab on a Chip’ technology is world-class and strongly aligns to Archer’s requirements for developing our key vertical of Human Health.

“One of the main reasons the company raised funds through the recent share purchase plan was to hire new staff to expedite the development of our deep tech and the prosecution of related patents.

“Dr Soffe’s appointment is consistent with this strategy, and we look forward to working with Dr Soffe and expanding our team and capabilities.”

International recognition

Dr Soffe started the role on September 9 based in Archer’s Sydney CBD office reporting directly to Archer’s CEO.

Her experience spans across the design, fabrication and integration of ‘lab on a chip’ biosensor devices.

She holds a PhD in Electrical and Computer Engineering from RMIT University, after receiving a Bachelor of Engineering with First Class Honours in Electrical and Electronic Engineering, University of Canterbury (New Zealand).

Her innovative work has been recognised internationally and published in peer-reviewed scientific journals which rank in the top percentiles in the field of nanotechnology that continue to be highly cited.

Archer's shares have been up as much as 14.6% in early trading to 67 cents.

Quick facts: Archer Materials Ltd

Price: 0.53 AUD

ASX:AXE
Market: ASX
Market Cap: $119.07 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Archer Material adds to graphene-based biosensor technology by producing it...

Archer Materials (ASX: AXE) CEO Dr Mohammad Choucair joined Steve Darling from Proactive with news the company has hit another milestone by using 3D technology to build proof-of-concept cartridge components for Archer’s biosensor devices. Mohammad talks about why this step is so important as...

2 weeks, 6 days ago

2 min read